ETANERCEPT
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | ETANERCEPT |
| DrugBank ID | DB00005 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 29 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| breast cancer | TxGNN Knowledge Graph | L5 |
| malignant epithelial tumor of ovary | TxGNN Knowledge Graph | L5 |
| glioblastoma (disease) | TxGNN Knowledge Graph | L5 |
| glioma susceptibility | TxGNN Knowledge Graph | L5 |
| squamous cell carcinoma of the corpus uteri | TxGNN Knowledge Graph | L5 |
| desmoplastic small round cell tumor | TxGNN Knowledge Graph | L5 |
| hereditary breast ovarian cancer syndrome | TxGNN Knowledge Graph | L5 |
| breast neoplasm | TxGNN Knowledge Graph | L5 |
| hereditary breast carcinoma | TxGNN Knowledge Graph | L5 |
| primary malignant peritoneal tumor | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11